These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 26827299

  • 1. Changing the approach to treatment choice in epilepsy using big data.
    Devinsky O, Dilley C, Ozery-Flato M, Aharonov R, Goldschmidt Y, Rosen-Zvi M, Clark C, Fritz P.
    Epilepsy Behav; 2016 Mar; 56():32-7. PubMed ID: 26827299
    [Abstract] [Full Text] [Related]

  • 2. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.
    Sirven JI, Shafer PO, Kalilani L, Wild I, Fishman J, Owens S.
    Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565
    [Abstract] [Full Text] [Related]

  • 3. Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.
    Shcherbakova N, Rascati K, Brown C, Lawson K, Novak S, Richards KM, Yoder L.
    CNS Drugs; 2014 Nov; 28(11):1047-58. PubMed ID: 25086640
    [Abstract] [Full Text] [Related]

  • 4. Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis.
    Faught E, Helmers S, Thurman D, Kim H, Kalilani L.
    Epilepsy Behav; 2018 Aug; 85():37-44. PubMed ID: 29906700
    [Abstract] [Full Text] [Related]

  • 5. What does the U.S. Medicare administrative claims database tell us about initial antiepileptic drug treatment for older adults with new-onset epilepsy?
    Martin RC, Faught E, Szaflarski JP, Richman J, Funkhouser E, Piper K, Juarez L, Dai C, Pisu M.
    Epilepsia; 2017 Apr; 58(4):548-557. PubMed ID: 28176298
    [Abstract] [Full Text] [Related]

  • 6. Newer antiepileptic drug use and other factors decreasing hospital encounters.
    Faught E, Helmers SL, Begley CE, Thurman DJ, Dilley C, Clark C, Fritz P.
    Epilepsy Behav; 2015 Apr; 45():169-75. PubMed ID: 25819943
    [Abstract] [Full Text] [Related]

  • 7. Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy use.
    Cramer JA, Wang ZJ, Chang E, Copher R, Cherepanov D, Broder MS.
    Epilepsy Behav; 2015 Mar; 44():40-6. PubMed ID: 25635369
    [Abstract] [Full Text] [Related]

  • 8. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy.
    Cramer JA, Wang ZJ, Chang E, Powers A, Copher R, Cherepanov D, Broder MS.
    Epilepsy Behav; 2014 Feb; 31():356-62. PubMed ID: 24239435
    [Abstract] [Full Text] [Related]

  • 9. Healthcare utilization and costs in children with stable and uncontrolled epilepsy.
    Cramer JA, Wang ZJ, Chang E, Powers A, Copher R, Cherepanov D, Broder MS.
    Epilepsy Behav; 2014 Mar; 32():135-41. PubMed ID: 24561658
    [Abstract] [Full Text] [Related]

  • 10. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
    Hansen RN, Nguyen HP, Sullivan SD.
    Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
    [Abstract] [Full Text] [Related]

  • 11. Clinical and economic burden of breakthrough seizures.
    Divino V, Petrilla AA, Bollu V, Velez F, Ettinger A, Makin C.
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [Abstract] [Full Text] [Related]

  • 12. Patterns of antiepileptic drug use in patients with potential refractory epilepsy in Texas Medicaid.
    Gupte-Singh K, Wilson JP, Barner JC, Richards KM, Rascati KL, Hovinga C.
    Epilepsy Behav; 2018 Oct; 87():108-116. PubMed ID: 30120071
    [Abstract] [Full Text] [Related]

  • 13. Treatment patterns in patients with a new diagnosis of epilepsy and psychiatric comorbidities.
    Kalilani L, Friesen D, Murray P.
    Epilepsy Behav; 2019 Oct; 99():106405. PubMed ID: 31487669
    [Abstract] [Full Text] [Related]

  • 14. Use of antiepileptic drugs and lipid-lowering agents in the United States.
    Mintzer S, Maio V, Foley K.
    Epilepsy Behav; 2014 May; 34():105-8. PubMed ID: 24735835
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL, Candrilli SD, Edin HM.
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [Abstract] [Full Text] [Related]

  • 16. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study.
    Kalilani L, Lu C, Pierre-Louis B, Gold M.
    Epilepsy Behav; 2017 Jul; 72():51-57. PubMed ID: 28575767
    [Abstract] [Full Text] [Related]

  • 17. Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study.
    Borghs S, Thieffry S, Noack-Rink M, Dedeken P, Hong LS, Byram L, Logan J, Chan J, Kiri V.
    BMC Neurol; 2017 Mar 23; 17(1):59. PubMed ID: 28335764
    [Abstract] [Full Text] [Related]

  • 18. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
    Groth A, Wilke T, Borghs S, Gille P, Joeres L.
    Ger Med Sci; 2017 Mar 23; 15():Doc09. PubMed ID: 28638313
    [Abstract] [Full Text] [Related]

  • 19. New-onset lesional and nonlesional epilepsy in the US population: Patient characteristics and patterns of antiepileptic drug use.
    Thurman DJ, Faught E, Helmers S, Kim H, Kalilani L.
    Epilepsy Res; 2019 Nov 23; 157():106210. PubMed ID: 31605878
    [Abstract] [Full Text] [Related]

  • 20. Effect of dosage failed of first antiepileptic drug on subsequent outcome.
    Brodie MJ, Barry SJ, Bamagous GA, Kwan P.
    Epilepsia; 2013 Jan 23; 54(1):194-8. PubMed ID: 23106423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.